Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Vivos Inc.
- Market Cap
- Unavailable
- Price
- $0.05368
- % Change (Daily % change from the live per-ticker quote feed.)
- -5.49%
- Volume
- 521.0K
About
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Quick stats
Shares outstanding—
Computed float474.7M
Float / sharesUnknown
Cash runway (months)9.4
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001449349
Websitehttps://www.radiogel.com
AI Summary
AI-generated1/21
majorbullishoperations update
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
Vivos has commenced commercial shipments of IsoPet from its new in-house U.S. production facility in Richland, WA, transitioning away from contract manufacturing to improve supply reliability and quality oversight.
Simultaneously, the company received authorization from India's Atomic Energy Regulatory Board (AERB) to establish an international manufacturing center in New Delhi, creating a dual-site global production network.
These milestones reduce single-site dependency and position the company to serve clinical and commercial markets across Asia, the Middle East, and Africa within a 7.5-hour transit window.